Legal & General Group PLC Adicet Bio, Inc. Transaction History

Legal & General Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.76 - $3.45 $3,520 - $6,900	2,000 Added 72.97%	4,741 $11,000
Q2 2023 Aug 14, 2023	SELL	$2.13 - $7.13 $2,078 - $6,958	-976 Reduced 26.26%	2,741 $6,000
Q1 2023 May 15, 2023	SELL	$5.52 - $9.23 $22,499 - $37,621	-4,076 Reduced 52.3%	3,717 $21,000
Q4 2022 Feb 14, 2023	BUY	$7.72 - $21.27 $3,829 - $10,549	496 Added 6.8%	7,793 $69,000
Q3 2022 Nov 14, 2022	BUY	$13.43 - $18.74 $12,610 - $17,596	939 Added 14.77%	7,297 $104,000
Q2 2022 Aug 22, 2022	BUY	$10.26 - $20.81 $43,810 - $88,858	4,270 Added 204.5%	6,358 $93,000
Q1 2022 May 16, 2022	BUY	$11.53 - $19.97 $4,865 - $8,427	422 Added 25.33%	2,088 $42,000
Q2 2021 Aug 12, 2021	BUY	$9.19 - $15.93 $15,310 - $26,539	1,666 New	1,666 $17,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.